Journal of Bone and Joint Surgery - British Volume, Vol 92-B, Issue 7, 929-934.
doi: 10.1302/0301-620X.92B7.24461  
Copyright © 2010 by British Editorial Society of Bone and Joint Surgery
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary material
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pedersen, A. B.
Right arrow Articles by Sørensen, H. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pedersen, A. B.
Right arrow Articles by Sørensen, H. T.

Risk of revision of a total hip replacement in patients with diabetes mellitus

A POPULATION-BASED FOLLOW UP STUDY

A. B. Pedersen, MD, PhD, Staff Specialist1; F. Mehnert, MSc, Statistician1; S. P. Johnsen, MD, PhD, Associate Professor1; and H. T. Sørensen, MD, DMSc, Professor1

1 Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes alle 43-45, 8200, Aarhus N, Denmark.

Correspondence should be sent to Dr A. B. Pedersen; e-mail: abp{at}dce.au.dk

We have evaluated the extent to which diabetes affects the revision rate following total hip replacement (THR). Through the Danish Hip Arthroplasty Registry we identified all patients undergoing a primary THR (n = 57 575) between 1 January 1996 and 31 December 2005, of whom 3278 had diabetes. The presence of diabetes among these patients was identified through the Danish National Registry of Patients and the Danish National Drug Prescription Database. We estimated the relative risk for revision and the 95% confidence intervals for patients with diabetes compared to those without, adjusting for the confounding factors. Diabetes is associated with an increased risk of revision due to deep infection (relative risk = 1.45 (95% confidence interval 1.00 to 2.09), particularly in those with type 2 diabetes (relative risk = 1.49 (95% confidence interval 1.02 to 2.18)), those with diabetes for less than five years prior to THR (relative risk = 1.69 (95% confidence interval 1.24 to 2.32)), those with complications due to diabetes (relative risk = 2.11 (95% confidence interval 1.41 to 3.17)), and those with cardiovascular comorbidities prior to surgery (relative risk = 2.35 (95% confidence interval 1.39 to 3.98)).

Patients and surgeons should be aware of the relatively elevated risk of revision due to deep infection following THR in diabetes particularly in those with insufficient control of their glucose level.






© British Editorial Society of Bone and Joint Surgery All Rights Reserved
Registered charity no: 209299, Print ISSN: 0301-620X
Hip, Knee, Trauma, Upper limb, Foot & Ankle, Paediatrics, Oncology, Spine, Arthroplasty, General